Results 61 to 70 of about 137,573 (297)

Prescription Drug Monitoring and Dispensing of Prescription Opioids [PDF]

Public Health Reports®, 2014
Objective. In the United States, per-capita opioid dispensing has increased concurrently with analgesic-related mortality and morbidity since the 1990s. To deter diversion and abuse of controlled substances, most states have implemented electronic prescription drug monitoring programs (PDMPs).
Joanne E, Brady, Hannah, Wunsch, Charles, DiMaggio, Barbara H, Lang, James, Giglio, Guohua, Li   +5 more
openaire   +2 more sources

Sertraline Treatment Can Mimic Niemann‐Pick Type C Biomarker Profile: A Diagnostic Pitfall

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Oxysterols (cholestane‐3β,5α,6β‐triol and 7‐ketocholesterol) and N‐palmitoyl‐O‐phosphocholineserine (PPCS) are sensitive biomarkers for Niemann‐Pick disease type C (NPC) screening. However, false‐positive results occur, with a biomarker profile suggestive of NPC despite the absence of pathogenic variants in genes involved in NPC or ...
Maria Makrygianni, Cecile Pagan, Antony Citterio‐Quentin, Isabelle Rouvet, Giulia Dingeo, Cyril Hanin, Claudine Laurent‐Levinson, Samia Pichard, Bénédicte Héron, Clément Gourguechon, Daniele Mandia, Jerome Guitton, Carole Lacout, Nicolas Schleinitz, Florient Potier, Olivier Flabeau, Elsa Besse‐Pinot, Foudil Lamari, Magali Pettazzoni, Yann Nadjar   +19 more
wiley   +1 more source

Drug-drug interactions in the hospital [PDF]

, 2007
Introduction Drug interaction screening programs are an important tool to check prescriptions of multiple drugs for potential drug-drug interactions (pDDIs). Several programs are available on the market.
Vonbach, Priska
core   +1 more source

Prescriptions errors: a comparison of handwritten and computerized prescriptions at Royal Medical Services, Jordan

Zagazig Journal of Pharmaceutical Sciences, 2014
Prescription errors are the most common errors of medical errors that may harm patients, so to decrease this problem computerized prescriptions are useful to be used instead of hand written, in this study we determine and compare the prevalence of ...
Ra’eda A.W al- Madadha , Mohammad A. Al-farajat , Amjad A. Alyazjeen , Hanan Masarweh , Tahani Alshqairat , Salah S. Haddadin , Yara Abu Taleb   +6 more
doaj   +1 more source

Mandatory Access Prescription Drug Monitoring Programs and Prescription Drug Abuse [PDF]

Journal of Policy Analysis and Management, 2018
AbstractDespite the significant cost of prescription (Rx) drug abuse and calls from policymakers for effective interventions, there is limited research on the effects of policies intended to limit such abuse. This study estimates the effects of prescription drug monitoring (PDMP) programs, which constitute a key policy targeting access to non‐medical ...
Anca M, Grecu, Dhaval M, Dave, Henry, Saffer   +2 more
openaire   +2 more sources

Efficacy of Inebilizumab in N‐MOmentum Trial Participants With or Without Prior Immunosuppressants

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT This post hoc analysis examined the impact of prior immunosuppressants on the long‐term efficacy and safety of inebilizumab, a cluster of differentiation 19+ B‐cell–depleting monoclonal antibody, in participants with aquaporin‐4–seropositive neuromyelitis optica spectrum disorder from the N‐MOmentum trial (NTC02200770).
Bruce A. C. Cree, Beatrice Suero, Sarah Walsh, Romain Marignier, John W. Lindsey, Ho Jin Kim, Dewei She, Daniel Cimbora, Dustin Cavida, Friedemann Paul   +9 more
wiley   +1 more source

Electroencephalographic Normalization as a Biomarker of Clinical Recovery in Down Syndrome Regression Disorder

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Down syndrome regression disorder is a syndrome characterized by subacute loss of cognitive, behavioral, and functional abilities in individuals with Down syndrome. Electroencephalography abnormalities are frequently observed during evaluation, but it remains unclear whether these findings represent a dynamic marker of disease ...
Jonathan D. Santoro, Mackenzie Silverman, Maeve C. Lucas, Mariam M. Yousuf, Samuel T. Otey, Stella V. Gray, Brittany Jordan, Madeline D. Kahan, Latanya D. Agurs, Michelle Van Hirtum Das, Deborah Holder, Devin King, Eileen A. Quinn, Ryan Kammeyer, Michael S. Rafii   +14 more
wiley   +1 more source

Potential Drug-drug Interactions Analysis in Children Out-patients with Bronchopneumonia Medication Prescriptions

Borneo Journal of Pharmacy, 2020
Drug-drug interactions (DDIs) is defined as the alteration of efficacy and toxicity of some drugs in the presence of other drugs. In the treatments of bronchopneumonia in outpatient settings, there is a lack of documentation of DDIs. This study was aimed
Ilil Maidatuz Zulfa, Fitria Dewi Yunitasari, Susanty Kartika Dewi   +2 more
doaj   +1 more source

The Effects of Drug Subsidies on Out-of Pocket Prescription Drug Expenditures by Seniors: Regional Evidence from Canada [PDF]

Between 1970 and 1986 all Canadian provinces introduced some version of a prescription drug subsidy for those age 65 or over and since 1986, all the provinces have increased copayments or deductibles to some degree.
Michael R. Veall, Sule Korkmaz, Paul Grootendorst, Thomas F. Crossley   +3 more
core   +3 more sources

Off-label and unlicensed drug use in a Spanish Neonatal Intensive Care Unit

Farmacia Hospitalaria, 2017
Objetive: To describe off-label and unlicensed drugs in clinical practice in a Neonatal Intensive Care Unit (NICU).Method: The design of the study was a descriptive and retrospective three months research in a NICU of a Spanish University Hospital.
Belén Cabezuelo Escribano, Vicente Arocas Casañ, Beatriz Garrido-Corro, Pablo de la Cruz Murie, Pablo de la Cruz Murie, Mª José Blázquez Álvarez, M.ª Amelia de la Rubia Nieto   +6 more
doaj   +1 more source